A recent study confirms that the 100-year-old BCG vaccine does not protect against COVID-19, challenging early assumptions ...
Following the Bacillus Calmette-Guérin shortage, the first patient with bladder cancer has been dosed with recombinant ...
A live-attenuated tuberculosis (TB) vaccine candidate in development elicits a much more balanced and effective immune response compared to the existing vaccine used across much of the world, ...
ImmunityBio, Inc. , a leading immunotherapy company, today announced U.S. Urology Partners, one of the nation's largest independent providers of urology and related specialty services, is one of the ...
L’administration Trump souffle le chaud et le froid sur le financement des programmes de lutte contre cette maladie ...
Introduction Vaccines are biological preparations that stimulate the immune system to develop protection against specific infectious diseases.
A dividend from immunisation is a future free from the diseases that rob communities of health and well-being, a future free ...
According to the company, the new, 225,000-square-foot expansion is a "crucial component" of a more than $12 billion infusion ...
Academic researchers in Massachusetts believe the standard BCG (bacillus Calmette-Guérin) vaccine could have a remarkable second use: a treatment to reverse advanced type 1 diabetes. The cause of ...
5h
Science Africa on MSNVaccination: Kenya Urged to Fulfil GAVI Co-financing ObligationBy Sharon AtienoKenya risks a vaccination crisis if the country does not honour its Global Alliance for Vaccines and ...
Merck says the expansion in Durham is part of more than $12 billion the company has invested in U.S. manufacturing and ...
With one of the largest tuberculosis (TB) outbreaks in US history, Kansas has more to worry about than its recent Super Bowl ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results